Rhythm Pharmaceuticals buy Morgan Stanley
Start price
19.12.23
/
50%
€42.40
Target price
19.12.24
€50.16
Performance (%)
5.66%
Price
26.08.24
€44.80
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley shows slight gains of 5.66%. This prediction currently runs until 19.12.24. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Rhythm Pharmaceuticals | 9.268% | 9.268% |
iShares Core DAX® | 1.560% | 4.721% |
iShares Nasdaq 100 | 0.517% | 1.171% |
iShares Nikkei 225® | 1.730% | 6.073% |
iShares S&P 500 | 1.482% | 1.218% |
Comments by Morgan_Stanley for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $55.00 price target on the stock, up previously from $29.00.
Ratings data for RYTM provided by MarketBeat